2,000 percent drug price surge is a side effect of FDA safety program
By Robert Langreth | Cynthia KoonsThe FDA rewarded a company for testing a gout treatment known to the ancient Greeks.
October 06, 2015
5 mysterious 2016 open enrollment period wildcardsThe third PPACA open enrollment may be as hard to analyze as the first, or the second.
October 02, 2015
Hedge Fund Exploits Changing Political ClimateInvestor reactions to political developments create mispricings in the market, says David Coggins of Coral Gables Asset Management.
October 02, 2015
Drugmaker tactic to block generics may violate law, FTC saysOfficials say "product-hopping" maintains a monopoly through illegal means.
October 02, 2015
These Female Clients Love Their Financial Advisors—Here’s WhyFor insight on how to best serve female clients, the Raymond James Womens Symposium turned to clients themselves.
September 30, 2015
Fed’s delay in raising rates reins in treasury selloff forecastsBenchmark yields will climb to 2.45 percent by the end of 2015, based on Bloomberg surveys of economists.
September 29, 2015
How free market medicine is disrupting and transforming marketsIt might sound like an impossible dream, but the concept of "free market medicine" is starting to transform the health care system.